Benzinga | Nov 23, 2021 07:17AM EST

JMP Securities Maintains Market Outperform on Enanta Pharmaceuticals, Raises Price Target to $116

JMP Securities analyst Jason Butler maintains Enanta Pharmaceuticals (NASDAQ:ENTA) with a Market Outperform and raises the price target from $111 to $116.